• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性免疫缺陷在化脓性汗腺炎发病机制及疾病负担中的作用。

Inborn Errors of Immunity in Hidradenitis Suppurativa Pathogenesis and Disease Burden.

机构信息

Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, USA.

Department of Dermatology, Vagelos College of Physicians & Surgeons, Columbia University, New York City, NY, USA.

出版信息

J Clin Immunol. 2023 Aug;43(6):1040-1051. doi: 10.1007/s10875-023-01518-3. Epub 2023 May 19.

DOI:10.1007/s10875-023-01518-3
PMID:37204644
Abstract

Hidradenitis suppurativa (HS), also known as Verneuil's disease and acne inversa, is a prevalent, debilitating, and understudied inflammatory skin disease. It is marked by repeated bouts of pathological inflammation causing pain, hyperplasia, aberrant healing, and fibrosis. HS is difficult to manage and has many unmet medical needs. There is clinical and pharmacological evidence for extensive etiological heterogeneity with HS, suggesting that this clinical diagnosis is capturing a spectrum of disease entities. Human genetic studies provide robust insight into disease pathogenesis. They also can be used to resolve etiological heterogeneity and to identify drug targets. However, HS has not been extensively investigated with well-powered genetic studies. Here, we review what is known about its genetic architecture. We identify overlap in molecular, cellular, and clinical features between HS and inborn errors of immunity (IEI). This evidence indicates that HS may be an underrecognized component of IEI and suggests that undiagnosed IEI are present in HS cohorts. Inborn errors of immunity represent a salient opportunity for rapidly resolving the immunological landscape of HS pathogenesis, for prioritizing drug repurposing studies, and for improving the clinical management of HS.

摘要

化脓性汗腺炎(HS),也称为 Vern e u il 病和反向痤疮,是一种常见的、使人衰弱的、研究不足的炎症性皮肤病。其特征是反复出现病理性炎症,导致疼痛、增生、异常愈合和纤维化。HS 难以治疗,有许多未满足的医疗需求。HS 的临床和药理学证据表明其病因具有广泛的异质性,表明这一临床诊断涵盖了一系列疾病实体。人类遗传学研究为疾病发病机制提供了有力的见解。它们还可用于解决病因异质性并确定药物靶点。然而,HS 并没有经过广泛的、具有强大效能的遗传研究。在这里,我们回顾了其遗传结构的已知内容。我们发现 HS 与先天性免疫缺陷(IEI)之间存在分子、细胞和临床特征的重叠。这一证据表明,HS 可能是 IEI 的一个未被充分认识的组成部分,并表明在 HS 患者群体中存在未被诊断的 IEI。先天性免疫缺陷为快速解析 HS 发病机制的免疫学特征、优先开展药物再利用研究以及改善 HS 的临床管理提供了重要机会。

相似文献

1
Inborn Errors of Immunity in Hidradenitis Suppurativa Pathogenesis and Disease Burden.先天性免疫缺陷在化脓性汗腺炎发病机制及疾病负担中的作用。
J Clin Immunol. 2023 Aug;43(6):1040-1051. doi: 10.1007/s10875-023-01518-3. Epub 2023 May 19.
2
A Comparison of International Management Guidelines for Hidradenitis Suppurativa.《化脓性汗腺炎国际管理指南比较》
Dermatology. 2021;237(1):81-96. doi: 10.1159/000503605. Epub 2019 Oct 23.
3
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
4
Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?化脓性汗腺炎/反向痤疮:一种内分泌皮肤疾病?
Rev Endocr Metab Disord. 2016 Sep;17(3):335-341. doi: 10.1007/s11154-016-9366-z.
5
Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.化脓性汗腺炎患病率的系统评价和荟萃回归分析。
JAMA Dermatol. 2021 Aug 1;157(8):924-931. doi: 10.1001/jamadermatol.2021.1677.
6
Hidradenitis suppurativa for the nondermatology clinician.非皮肤科临床医生的化脓性汗腺炎
Proc (Bayl Univ Med Cent). 2020 Jul 27;33(4):586-591. doi: 10.1080/08998280.2020.1793643.
7
What causes hidradenitis suppurativa ?-15 years after.化脓性汗腺炎的病因是什么?——15 年后的研究进展
Exp Dermatol. 2020 Dec;29(12):1154-1170. doi: 10.1111/exd.14214.
8
Hidradenitis suppurativa.化脓性汗腺炎。
Med Clin (Barc). 2024 Feb 23;162(4):182-189. doi: 10.1016/j.medcli.2023.09.018. Epub 2023 Nov 13.
9
Hidradenitis Suppurativa: Comprehensive Review of Predisposing Genetic Mutations and Changes.化脓性汗腺炎:易患遗传突变和变化的综合综述。
J Cutan Med Surg. 2019 Sep/Oct;23(5):519-527. doi: 10.1177/1203475419852049. Epub 2019 Jun 6.
10
Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa.长波医疗红外热成像:化脓性汗腺炎/反向痤疮炎症的临床生物标志物。
Dermatology. 2019;235(2):144-149. doi: 10.1159/000495982. Epub 2019 Jan 16.

引用本文的文献

1
The polygenic architecture of hidradenitis suppurativa reveals signaling mechanisms that implicate epithelial remodeling.化脓性汗腺炎的多基因结构揭示了涉及上皮重塑的信号传导机制。
medRxiv. 2025 Jul 28:2025.07.25.25332168. doi: 10.1101/2025.07.25.25332168.
2
Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management.利用基因型和表型在化脓性汗腺炎管理中实施精准医学。
Br J Dermatol. 2025 Feb 3;192(Supplement_1):i22-i29. doi: 10.1093/bjd/ljae399.
3
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa.

本文引用的文献

1
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.尼拉格塞特,一种针对硬纤维瘤的γ-分泌酶抑制剂。
N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140.
2
Contribution of genetic variants associated with primary immunodeficiencies to childhood-onset systemic lupus erythematous.与原发性免疫缺陷相关的基因变异对儿童期起病的系统性红斑狼疮的影响。
J Allergy Clin Immunol. 2023 Apr;151(4):1123-1131. doi: 10.1016/j.jaci.2022.12.807. Epub 2022 Dec 28.
3
Identification of variants in genes associated with autoinflammatory disorders in a cohort of patients with psoriatic arthritis.
化脓性汗腺炎患者的血清免疫球蛋白G水平及Nicastrin变异
JAMA Dermatol. 2025 Apr 1;161(4):411-415. doi: 10.1001/jamadermatol.2024.5684.
4
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study.化脓性汗腺炎老年患者的临床特征及治疗反应:一项队列研究
J Clin Med. 2023 Dec 18;12(24):7754. doi: 10.3390/jcm12247754.
5
Inborn Errors of Immunity Contribute to the Burden of Skin Disease and Create Opportunities for Improving the Practice of Dermatology.先天免疫缺陷导致皮肤疾病负担加重,并为改善皮肤病学实践提供了机会。
J Invest Dermatol. 2024 Feb;144(2):307-315.e1. doi: 10.1016/j.jid.2023.08.018. Epub 2023 Sep 15.
6
Clinical and Molecular Characterization of Hidradenitis Suppurativa: A Practical Framework for Novel Therapeutic Targets.化脓性汗腺炎的临床与分子特征:新型治疗靶点的实用框架。
Dermatology. 2023;239(5):836-839. doi: 10.1159/000531496. Epub 2023 Jun 10.
在一组银屑病关节炎患者中鉴定与自身炎症性疾病相关的基因变异。
RMD Open. 2022 Sep;8(2). doi: 10.1136/rmdopen-2022-002561.
4
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.泛癌种携带致病变异体种系变异患者的种族/民族差异与癌症遗传学护理。
Cancer. 2022 Nov 1;128(21):3870-3879. doi: 10.1002/cncr.34434. Epub 2022 Aug 30.
5
Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa.压力信号和 STAT1 激活是化脓性汗腺炎角质形成细胞基因表达模式的特征。
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2488-2498. doi: 10.1111/jdv.18465. Epub 2022 Aug 9.
6
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin.人 OTULIN 杂合不足会损害细胞内在对金黄色葡萄球菌α-毒素的免疫。
Science. 2022 Jun 17;376(6599):eabm6380. doi: 10.1126/science.abm6380.
7
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.未满足的临床需求和疾病负担:来自欧盟 5 国和美国的真实世界经验。
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1597-1605. doi: 10.1111/jdv.18163. Epub 2022 May 9.
8
Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.美国免疫缺陷网注册中心的先天性免疫缺陷患者中的风湿性疾病。
Clin Rheumatol. 2022 Jul;41(7):2197-2203. doi: 10.1007/s10067-021-06044-4. Epub 2022 Jan 31.
9
Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.Janus 激酶 1 抑制剂 INCB054707 治疗中重度化脓性汗腺炎患者:两项 II 期研究结果。
Br J Dermatol. 2022 May;186(5):803-813. doi: 10.1111/bjd.20969. Epub 2022 Mar 6.
10
DNA-Binding domain mutations confer severe outcome at an early age among STAT1 gain-of-function patients.在信号转导和转录激活因子1(STAT1)功能获得性患者中,DNA结合域突变在早年就会导致严重后果。
Pediatr Allergy Immunol. 2022 Jan;33(1):e13694. doi: 10.1111/pai.13694. Epub 2021 Nov 18.